Advances in Clinical Chemistry, Volume 124 provides the fundamentals of physiologic and pathophysiologic biochemistry in general and clinical chemistry. Complex molecular pathways are elucidated using historical, current, and emerging technologies such as biosensor design and development. Identification of novel biomarkers and accurate and precise analysis are key to cutting-edge patient care, diagnostics, and treatment. This series strategically focuses on new tools for the detection of novel biomarkers, especially in light of an aging worldwide population faced with increased prevalence of chronic disease, many of which lack early diagnostic tools that are so essential to patient care and socioeconomic outcome.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: Emerging biomarkers in Gaucher disease - p. 1 8. Chapter Two: Visceral fat distribution: Interracial studies - p. 57 9. Chapter Three: Lupus nephritis: Biomarkers - p. 87 10. Chapter Four: Ion mobility spectrometry and ion mobility-mass spectrometry in clinical chemistry - p. 123 11. Chapter Five: Multiomics in cancer biomarker discovery and cancer subtyping - p. 161 12. Chapter Six: Urinary biomarkers of preeclampsia: An update - p. 197 13. Index - p. 213
Advances in Clinical Chemistry, Volume 124 provides the fundamentals of physiologic and pathophysiologic biochemistry in general and clinical chemistry. Complex molecular pathways are elucidated using historical, current, and emerging technologies such as biosensor design and development. Identification of novel biomarkers and accurate and precise analysis are key to cutting-edge patient care, diagnostics, and treatment. This series strategically focuses on new tools for the detection of novel biomarkers, especially in light of an aging worldwide population faced with increased prevalence of chronic disease, many of which lack early diagnostic tools that are so essential to patient care and socioeconomic outcome.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: Emerging biomarkers in Gaucher disease - p. 1 8. Chapter Two: Visceral fat distribution: Interracial studies - p. 57 9. Chapter Three: Lupus nephritis: Biomarkers - p. 87 10. Chapter Four: Ion mobility spectrometry and ion mobility-mass spectrometry in clinical chemistry - p. 123 11. Chapter Five: Multiomics in cancer biomarker discovery and cancer subtyping - p. 161 12. Chapter Six: Urinary biomarkers of preeclampsia: An update - p. 197 13. Index - p. 213
